264 related articles for article (PubMed ID: 28267648)
21. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
[TBL] [Abstract][Full Text] [Related]
22. Plasma and synovial fluid programmed cell death 5 (PDCD5) levels are inversely associated with TNF-α and disease activity in patients with rheumatoid arthritis.
Wang J; Guan Z; Ge Z
Biomarkers; 2013 Mar; 18(2):155-9. PubMed ID: 23327497
[TBL] [Abstract][Full Text] [Related]
23. Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis.
Szeremeta A; Jura-Półtorak A; Koźma EM; Głowacki A; Kucharz EJ; Kopeć-Mędrek M; Olczyk K
Arthritis Res Ther; 2018 Sep; 20(1):211. PubMed ID: 30227885
[TBL] [Abstract][Full Text] [Related]
24. Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia.
Hock BD; Fernyhough LJ; Gough SM; Steinkasserer A; Cox AG; McKenzie JL
Leuk Res; 2009 Aug; 33(8):1089-95. PubMed ID: 19195701
[TBL] [Abstract][Full Text] [Related]
25. Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.
Sfriso P; Caso F; Filardo GS; Botsios C; Costa L; Scarpa R; Todesco S; Spinella P; Oliviero F; Punzi L
Clin Rheumatol; 2016 Jun; 35(6):1615-8. PubMed ID: 27048267
[TBL] [Abstract][Full Text] [Related]
26. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B
Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
[TBL] [Abstract][Full Text] [Related]
27. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis.
Kopp S; Alstergren P; Ernestam S; Nordahl S; Morin P; Bratt J
Cells Tissues Organs; 2005; 180(1):22-30. PubMed ID: 16088130
[TBL] [Abstract][Full Text] [Related]
28. Increased levels of circulating soluble CD14 but not CD83 in infants are associated with early intestinal colonization with Staphylococcus aureus.
Lundell AC; Adlerberth I; Lindberg E; Karlsson H; Ekberg S; Aberg N; Saalman R; Hock B; Steinkasserer A; Hesselmar B; Wold AE; Rudin A
Clin Exp Allergy; 2007 Jan; 37(1):62-71. PubMed ID: 17210043
[TBL] [Abstract][Full Text] [Related]
29. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.
Reparon-Schuijt CC; van Esch WJ; van Kooten C; Levarht EW; Breedveld FC; Verweij CL
Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878
[TBL] [Abstract][Full Text] [Related]
30. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
31. Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.
Laustsen JK; Rasmussen TK; Stengaard-Pedersen K; Hørslev-Petersen K; Hetland ML; Østergaard M; Junker P; Hvid M; Deleuran B
Arthritis Res Ther; 2014 Oct; 16(5):474. PubMed ID: 25359291
[TBL] [Abstract][Full Text] [Related]
32. A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis.
Xibillé-Friedmann D; Bustos Rivera-Bahena C; Rojas-Serrano J; Burgos-Vargas R; Montiel-Hernández JL
Scand J Rheumatol; 2013; 42(2):102-7. PubMed ID: 23244209
[TBL] [Abstract][Full Text] [Related]
33. Serum-soluble folate receptor β as a biomarker for the activity of rheumatoid arthritis synovitis and the response to anti-TNF agents.
Otsubo H; Tsuneyoshi Y; Nakamura T; Matsuda T; Komiya S; Matsuyama T
Clin Rheumatol; 2018 Nov; 37(11):2939-2945. PubMed ID: 30022370
[TBL] [Abstract][Full Text] [Related]
34. Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.
Yoshida Y; Ogata A; Kang S; Ebina K; Shi K; Nojima S; Kimura T; Ito D; Morimoto K; Nishide M; Hosokawa T; Hirano T; Shima Y; Narazaki M; Tsuboi H; Saeki Y; Tomita T; Tanaka T; Kumanogoh A
Arthritis Rheumatol; 2015 Jun; 67(6):1481-90. PubMed ID: 25707877
[TBL] [Abstract][Full Text] [Related]
35. BDNF in RA: downregulated in plasma following anti-TNF treatment but no correlation with inflammatory parameters.
Grimsholm O; Rantapää-Dahlqvist S; Dalén T; Forsgren S
Clin Rheumatol; 2008 Oct; 27(10):1289-97. PubMed ID: 18484150
[TBL] [Abstract][Full Text] [Related]
36. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
Brennan FM; Gibbons DL; Mitchell T; Cope AP; Maini RN; Feldmann M
Eur J Immunol; 1992 Jul; 22(7):1907-12. PubMed ID: 1320571
[TBL] [Abstract][Full Text] [Related]
37. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis.
Wan B; Nie H; Liu A; Feng G; He D; Xu R; Zhang Q; Dong C; Zhang JZ
J Immunol; 2006 Dec; 177(12):8844-50. PubMed ID: 17142787
[TBL] [Abstract][Full Text] [Related]
38. CD83 is locally regulated and differentially expressed in disturbed murine pregnancy.
Einenkel R; Packhäuser KRH; Ehrhardt J; Tüngler A; Zygmunt M; Muzzio DO
Reproduction; 2019 Oct; 158(4):323-333. PubMed ID: 31426030
[TBL] [Abstract][Full Text] [Related]
39. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
[TBL] [Abstract][Full Text] [Related]
40. Maturation and cytokine production potential of dendritic cells isolated from rheumatoid arthritis patients peripheral blood and induced in vitro.
Sennikov SV; Falaleeva SA; Shkaruba NS; Chumasova OA; Obleukhova IA; Sizikov AE; Kurilin VV
Hum Immunol; 2016 Oct; 77(10):930-936. PubMed ID: 27421624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
